CIL, the world leader in the separation of 18O and
13C isotopes for medical applications
and the world's largest supplier of stable isotope labeled research compounds, is pleased
to announce that the expansion of CIL's 18O separation facility, completed at the end of
2002, has increased CIL's production capacity of 18O to over 250kg per year.
With our breadth of experience and expertise in GMP/FDA medical products, CIL is very
responsive to the growing needs of the PET community for consistently high quality
product delivered on time at a fair price. CIL has made a significant investment in the
future of 18O applications for both PET and metabolism studies of energy expenditure.